Amit Sharma, MD
Family Medicine · Westmont, ILNPI 1538479332
Payments from drug & device makers
Across 154 payments — averaging $21.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$825
- Abbott$382
- Amgen$333
- Lilly USA, LLC$268
- AstraZeneca$214
- Boehringer Ingelheim$176
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,27399%
- Education$251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 48 | $825 |
| Abbott | 2 | $382 |
| Amgen | 18 | $333 |
| Lilly USA, LLC | 14 | $268 |
| AstraZeneca | 10 | $214 |
| Boehringer Ingelheim | 8 | $176 |
| Novo Nordisk | 8 | $156 |
| Pfizer | 7 | $134 |
| GSK | 6 | $131 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $78 |
| Exact Sciences | 3 | $72 |
| Currax Pharmaceuticals LLC | 4 | $67 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $66 |
| Idorsia Pharmaceuticals US Inc | 2 | $47 |
| Johnson & Johnson | 2 | $40 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
| Astellas Pharma US Inc | 1 | $24 |
| Almatica Pharma LLC | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Merck | 1 | $14 |
| Lucid Diagnostics Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ETERNA$382
How this compares
$3,298 in reported general payments places this provider in the 85th percentile of 4,116 family medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 62 | $68,028 |
| EliquisApixaban | 28 | $38,741 |
| Abilify MaintenaAripiprazole | 12 | $37,501 |
| OzempicSemaglutide | 17 | $33,658 |
| XareltoRivaroxaban | 19 | $30,276 |
| TrulicityDulaglutide | 19 | $27,440 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $24,243 |
| FarxigaDapagliflozin Propanediol | 13 | $22,500 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $9,564 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 12 | $8,861 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $8,401 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 33 | $6,594 |
| TrintellixVortioxetine Hydrobromide | 11 | $5,571 |
| Atorvastatin Calcium | 408 | $3,553 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 59 | $2,972 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $176 | $68,02862 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $131 | $42,20950 claims |
| PfizerEliquis | $134 | $38,74128 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $78 | $37,50112 claims |
| Novo NordiskOzempic | $156 | $33,65817 claims |
| Johnson & JohnsonXarelto | $40 | $30,27619 claims |
| Lilly USA, LLCTrulicity | $268 | $27,44019 claims |
| AstraZenecaFarxiga | $214 | $22,50013 claims |
| AbbVieSynthroid | $825 | $88117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Westmont
- Anthony AuriemmaWestmont$788K
- Paula BarnesWestmont$182K
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.